206 related articles for article (PubMed ID: 12808063)
1. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
[TBL] [Abstract][Full Text] [Related]
2. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation.
Pizem J; Cör A; Gale N
Histopathology; 2004 Aug; 45(2):180-6. PubMed ID: 15279637
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
[TBL] [Abstract][Full Text] [Related]
4. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.
Takai N; Miyazaki T; Nishida M; Nasu K; Miyakawa I
Int J Mol Med; 2002 Aug; 10(2):211-6. PubMed ID: 12119561
[TBL] [Abstract][Full Text] [Related]
5. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
[TBL] [Abstract][Full Text] [Related]
7. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
Zhang Y; Huang D; Yu G
Acta Otolaryngol; 2005 Dec; 125(12):1345-50. PubMed ID: 16303685
[TBL] [Abstract][Full Text] [Related]
8. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T
Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
[TBL] [Abstract][Full Text] [Related]
10. Survivin expression and its clinical significance in pancreatic cancer.
Lee MA; Park GS; Lee HJ; Jung JH; Kang JH; Hong YS; Lee KS; Kim DG; Kim SN
BMC Cancer; 2005 Oct; 5():127. PubMed ID: 16202147
[TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
13. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
15. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C
Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599
[TBL] [Abstract][Full Text] [Related]
16. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
17. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.
Tanaka K; Iwamoto S; Gon G; Nohara T; Iwamoto M; Tanigawa N
Clin Cancer Res; 2000 Jan; 6(1):127-34. PubMed ID: 10656440
[TBL] [Abstract][Full Text] [Related]
18. Correlation between survivin expression and prognosis in non-small cell lung cancer.
Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
Kawasaki H; Altieri DC; Lu CD; Toyoda M; Tenjo T; Tanigawa N
Cancer Res; 1998 Nov; 58(22):5071-4. PubMed ID: 9823313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]